Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CRL
CRL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CRL News
Mixed Performance in US Stock Indices, Chipmakers Lead Gains
3d ago
NASDAQ.COM
U.S. Stocks Rise, Led by Chipmakers Amid Strong Retail Sales
3d ago
NASDAQ.COM
Morgan Stanley Upgrades Charles River, Downgrades IQVIA Amid Biopharma Funding Boost
3d ago
seekingalpha
Latest Wall Street Ratings Overview
3d ago
CNBC
Major Wall Street Rating Changes Overview
May 29 2026
CNBC
Cold Chain Monitoring Market Expands Rapidly
May 22 2026
Yahoo Finance
Charles River Laboratories Q1 2026 Results Exceed Expectations
May 11 2026
Yahoo Finance
Charles River Labs Q1 Earnings Beat Estimates but Lowers FY2026 Forecast
May 08 2026
Newsfilter
Charles River Laboratories Set to Announce Q1 Earnings on May 7
May 06 2026
seekingalpha
Charles River Laboratories to Release Q1 2026 Financial Results
Apr 16 2026
Newsfilter
RBC Capital Markets Initiates Outperform Rating on CRL Amid NAMs Disruption
Apr 14 2026
seekingalpha
Latest Rating Changes on Wall Street
Apr 14 2026
CNBC
Charles River Laboratories Partners with American Heart Association for Cardiovascular Health
Apr 09 2026
Newsfilter
Booking Holdings Plummets 96.8% Year-to-Date
Apr 06 2026
NASDAQ.COM
NYSE Issues Daily Pre-Market Advisory
Apr 06 2026
PRnewswire
CNBC Launches Advocacy Platform for Rare Diseases
Mar 20 2026
CNBC
Show More News
